Fintel reports that on November 7, 2025, D. Boral Capital maintained coverage of AVITA Medical (NasdaqCM:RCEL) with a Buy ...

Fintel reports that on November 7, 2025, Evercore ISI Group maintained coverage of Omada Health (NasdaqGS:OMDA) with a ...

Health care fraud enforcement remains a top priority of the Trump administration, warns a law firm specializing in False ...

Sovato has completed a Series B financing round to accelerate the development of its teleoperated robotic surgery system, ...

UniQure said the U.S. Food and Drug Administration no longer agreed that clinical data for the Dutch company's gene therapy ...

Amgen on Tuesday reported quarterly financial results that beat Wall Street expectations, and raised its full-year outlook, ...

New work requirements are expected to leave millions of poor Americans uninsured. For Equifax, which charges states steep ...

Investors are watching for private updates on the job market as the government shutdown is days away from becoming the ...

Get the latest on MindMed’s Q3 2025 earnings: clinical trial milestones, financial strength, and pivotal Phase III data readouts expected in 2026.

Investing in pharmaceutical companies with diversified revenue bases and strong R&D pipelines could be a lucrative strategy.

The COLA boost is slightly better than earlier estimates, even if we're not talking about a lot of money. But many retirees ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. ProQR ( (PRQR) ) has issued an ...